XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Accounting Policies [Abstract] |
SCHEDULE OF DISAGGREGATED REVENUE | For the three and six months ended June 30, 2024 and 2023, the Company had the following disaggregated revenue: SCHEDULE OF DISAGGREGATED REVENUE
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | % |  |  | 2023 |  |  | % |  |  | 2024 |  |  | % |  |  | 2023 |  |  | % |
Telehealth revenue |  | $ | 20,519,165 |  |  |  | 41 | % |  | $ | 21,915,088 |  |  |  | 61 | % |  | $ | 41,784,029 |  |  |  | 44 | % |  | $ | 41,760,142 |  |  |  | 61 | %
LifeMD PC subscription revenue |  |  | 13,881,894 |  |  |  | 27 | % |  |  | 436,040 |  |  |  | 1 | % |  |  | 21,489,682 |  |  |  | 23 | % |  |  | 793,789 |  |  |  | 1 | %
WorkSimpli revenue |  |  | 13,229,536 |  |  |  | 26 | % |  |  | 13,595,785 |  |  |  | 38 | % |  |  | 26,532,398 |  |  |  | 28 | % |  |  | 26,519,317 |  |  |  | 38 | %
Medifast collaboration revenue |  |  | 3,031,250 |  |  |  | 6 | % |  |  | - |  |  |  | - | % |  |  | 5,000,000 |  |  |  | 5 | % |  |  | - |  |  |  | - | %
Total net revenue |  | $ | 50,661,845 |  |  |  | 100 | % |  | $ | 35,946,913 |  |  |  | 100 | % |  | $ | 94,806,109 |  |  |  | 100 | % |  | $ | 69,073,248 |  |  |  | 100 | %
SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY | The following table summarizes deferred revenue activities for the periods presented: SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Beginning of period |  | $ | 13,202,757 |  |  | $ | 5,895,545 |  |  | $ | 8,828,598 |  |  | $ | 5,547,506 |
Additions |  |  | 50,449,028 |  |  |  | 33,760,427 |  |  |  | 95,042,515 |  |  |  | 64,965,817 |
Revenue recognized |  |  | (48,490,126 | ) |  |  | (33,987,762 | ) |  |  | (88,709,454 | ) |  |  | (64,845,113 | )
End of period |  | $ | 15,161,659 |  |  | $ | 5,668,210 |  |  | $ | 15,161,659 |  |  | $ | 5,668,210 |
SUMMARY OF INVENTORY | As of June 30, 2024 and December 31, 2023, the Company’s inventory consisted of the following: SUMMARY OF INVENTORY
|  | June 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Finished goods |  | $ | 1,022,027 |  |  | $ | 1,216,833 |
Raw materials and packaging components |  |  | 1,379,436 |  |  |  | 1,898,784 |
Inventory reserve |  |  | (340,744 | ) |  |  | (355,685 | )
Total inventory, net |  | $ | 2,060,719 |  |  | $ | 2,759,932 |
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES | The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares: SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Series B Preferred Stock |  |  | - |  |  |  | 1,548,594 |  |  |  | - |  |  |  | 1,493,991 |
RSUs and RSAs |  |  | 2,279,750 |  |  |  | 2,788,000 |  |  |  | 2,296,125 |  |  |  | 2,341,438 |
Stock options |  |  | 1,527,000 |  |  |  | 3,463,753 |  |  |  | 1,843,375 |  |  |  | 3,667,003 |
Warrants |  |  | 1,743,730 |  |  |  | 4,827,380 |  |  |  | 2,068,419 |  |  |  | 4,827,380 |
Convertible long-term debt |  |  | 671,141 |  |  |  | 1,342,282 |  |  |  | 671,141 |  |  |  | 1,342,282 |
Potentially dilutive securities |  |  | 6,221,621 |  |  |  | 13,970,009 |  |  |  | 6,879,060 |  |  |  | 13,672,094 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration